Toronto, Ontario – (Newsfile Corp. – November 23, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“vivo“or the”a company‘), a leading provider of medical cannabis products and patient services, licensed under cannabis law Through its wholly owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc. Today, it announced the launch of its newest formulation of medical cannabis products: high-dose CBD oil under its Beacon Medical™ brand.
Beacon Medical™ 2: 100 High Dose CBD Oil is a distillate-based cannabis oil containing 100 mg of CBD and less than 2 mg of THC. All Bacon Medical™ Oil products are formulated with a non-GMO Medium Chain Triglyceride (MCT) carrier oil resulting in the end product being odorless and tasteless.
“With our commitment to the medical cannabis market, the team at VIVO aspire to provide high-quality cannabis-based medical products to our patients, and Beacon Medical™ CBD + | NS It was launched in response to patient insights that our team has collected over time,” commented Ray Laflame, Canna Farms co-founder and CEO of VIVO. We understand that many of our patients are looking for products that meet their individual needs, and this latest addition to Beacon Medical’s line of products is an excellent high potency CBD option for patients and will be available to patients, clinicians, and hospitals alike. “
CBD beacon + | O [2:100] Ultra-Strength CBD Oil to Help Patients Reach Their Health Goals
To view an improved version of this graphic, please visit:
VIVO simultaneously announced the launch of a Compassionate Care Program for Children To support caregivers and families who need medical cannabis to treat a variety of children’s conditions. Eligible patients will receive deep discounts on all Beacon Medical™, Canna Farms™, Fireside™ and Lumina™ CBD products.
VIVO stands firmly in a patient first approach that ensures consistent selection, access and provision of patients. Beacon Medical™ products are available exclusively in select medical markets in Canada, Australia and Germany.
The newly launched Beacon Medical™ High CBD Oil is available from Canna Farms E-Commerce Medical marketplace for Canadian medical clients. Patients who require support with registration or submission of applications can contact VIVO’s Customer Service team at (855) 882 0988 or firstname.lastname@example.org.
About VIVO Cannabis™
VIVO Cannabis™ has been recognized for premium and reliable cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal growing facilities. VIVO owns a portfolio of medical, health and wellness brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™ and Lumina™. Harvest Medicine™, VIVO’s patient-centered and scalable network of medical cannabis clinics, has served more than 150,000 patient visits. VIVO is pursuing various partnership and product development opportunities and focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com.
for further information:
VIVO المستثمرين Investor Relations
Facebook social network: https://www.facebook.com/vivocanna/
Disclaimer of forward-looking information
Certain statements in this press release are forward-looking statements, which are statements that are not purely historical, including statements regarding VIVO’s beliefs, plans, expectations or intentions and its management with respect to the future. These statements are subject to risks and uncertainties that could cause actual results, performance or developments to differ materially from those contained in the forward-looking statements. No guarantee can be given that any of the events foreseen by the forward-looking statements will occur or, if they do occur, what benefits the company will derive from them. Readers are encouraged to consider these factors carefully, along with the more comprehensive risk factors included in the Company’s management’s recent discussion and analysis available on SEDAR, in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, Restricted in its entirety to these cautionary statements. The forward-looking statements contained in this news release are made as of the date of this release and the Company disclaims any intention or obligation to publicly update any forward-looking statements, whether as a result of new information, events, future results or otherwise, except as required by laws applicable securities.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104861